The Bone Cements Market continues to expand at a steady pace as the demand for joint and spine surgeries increases worldwide. The market reached USD 781 Million in 2024 and is expected to grow to USD 1,113.68 Million by 2031, registering a 5.2% CAGR during 2025–2031. This growth is driven by the rising aging population, growing cases of osteoporosis, and increasing adoption of advanced surgical materials for better fixation and long-term implant stability.
Understanding Bone Cements
Bone cement is a medical-grade material used to anchor artificial joints and fill the spaces between prosthetic implants and natural bone. It plays a major role in joint replacement surgeries, vertebral augmentation, and revision procedures. Due to its strength, quick-setting ability, and durability, bone cement is widely used in hip, knee, shoulder, and spine surgeries.
Low, medium, and high-viscosity bone cements allow surgeons to choose the right option depending on patient needs and surgical technique.
Market Drivers Supporting Growth
The Bone Cements Market is strongly supported by several key factors:
-
Growing number of orthopedic surgeries, especially hip and knee replacements.
-
Increasing cases of bone-related disorders, including osteoporosis and spinal fractures.
-
Continuous improvements in PMMA-based formulations, helping reduce infection risk.
-
Greater adoption of minimally invasive spine procedures, leading to higher demand for vertebral cements.
-
Technological advancements by major companies to launch high-performance antibiotic-loaded cements.
Because of these drivers, the adoption of bone cements is increasing across hospitals, specialty orthopedic centers, and spine care facilities.
Latest News & Industry Updates (With Exact Dates)
The market has seen several important updates recently. These announcements reflect growing innovation, increased clinical validation, and more product activity across regions.
11 March 2025 — Zimmer Biomet Announces Launch of TEKCEM 1G & TEKCEM 3G in India
On 11 March 2025, Zimmer Biomet introduced two antibiotic-loaded bone cements—TEKCEM 1G and TEKCEM 3G—for joint fixation applications. These cements are designed to offer better infection control and improved prosthesis stability, strengthening the company’s portfolio in arthroplasty solutions.
23 April 2024 — FDA Clears Expanded Indications for OsteoRemedies SPECTRUM® GV Bone Cement
On 23 April 2024, OsteoRemedies received expanded FDA approval for the SPECTRUM GV dual-antibiotic bone cement, allowing its use in revision hip arthroplasty and second-stage procedures after infection removal. This milestone expands its clinical relevance and supports wider hospital adoption.
17 July 2025 — Heraeus Medical Highlights New PALACOS® Clinical Evidence
On 17 July 2025, Heraeus Medical published a new analysis from the Catalonia arthroplasty registry, confirming strong outcomes for PALACOS antibiotic bone cements. The report showed lower revision rates and stronger long-term performance in knee arthroplasty patients.
2025 — TEKNIMED Updates TEKCEM Portfolio Information
In 2025, TEKNIMED refreshed its TEKCEM product range information, boosting visibility for surgeons and distributors. These updates reflect active market engagement and highlight stronger global interest in the TEKCEM bone cement line.
2024–2025 — Tecres Strengthens Product Presence at Global Events
Tecres, which manufactures bone cement for multiple OEM brands, continued its 2024–2025 activity at international orthopedic conferences, promoting its solutions such as the RALLY portfolio. The company remains an important contributor to the global bone cement supply chain.
Market Segmentation
Product Types
The market is divided into:
-
Low Viscosity Cements
-
Medium Viscosity Cements
-
High Viscosity Cements
High-viscosity cements remain the most widely used due to their easier handling and fast setting time during arthroplasty.
Application
-
Joint (hip, knee, and shoulder replacement surgeries)
-
Vertebral (spinal fracture treatment, vertebroplasty, kyphoplasty)
The joint segment accounts for the largest share as knee and hip replacements continue to rise every year.
Sales Channel
-
Direct Channel
-
Distribution Channel
Manufacturers rely heavily on hospital partnerships and orthopedic distributors for global reach.
Regional Outlook
North America and Europe remain mature markets with high procedure volumes, while Asia-Pacific is the fastest-growing region due to its rapidly aging population and rising adoption of advanced orthopedic care.
Leading Companies in the Market
Key players shaping the Bone Cements Market include:
Stryker, Johnson & Johnson, Heraeus Medical, Smith & Nephew, B. Braun Melsungen AG, Medtronic, Alphatec Spine, DJO Global, Tecres, Osseon, Somatex Medical Technologies, Medacta International, Cook Medical, TEKNIMED, G-21, and TSMRI.
Their focus remains on expanding clinical evidence, improving cement formulations, and delivering products that reduce infection and improve implant fixation.
Future Outlook
The Bone Cements Market is expected to grow steadily through 2031. The combination of advanced formulations, antibiotic-loaded products, and rising orthopedic procedure counts will keep demand strong. Furthermore, new technologies and improved safety features will continue to attract hospitals, orthopedic surgeons, and spine care centers worldwide.
As more companies invest in innovation and emerging economies upgrade their healthcare infrastructure, the global market for bone cements is set to remain on a long-term growth path.
